Congenital Microtia: Clinical Trials

33 trials for Congenital Microtia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 8 unknown, 5 terminated, 4 recruiting. 15 Not applicable, 5 Phase 2, 4 Phase 1, 2 Early Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 6, Not yet recruiting 3, Recruiting 2, Unknown 2, Terminated 1, Withdrawn 1
Phase 25Terminated 3, Recruiting 1, Unknown 1
Phase 14Terminated 4
Early Phase 12Completed 1, Withdrawn 1
Phase 42Unknown 2

Follow Congenital Microtia: new trials by email Literature Review of Congenital Microtia trials Research Report on Congenital Microtia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deep Learning for Flap Perfusion Detection
AI-assisted remote monitoring of flap perfusion abnormalities after first-stage auricular reconstruction - Congenital Microtia
Not applicableNot yet recruitingJing Xu2322026-09-222026-09-29
Case Management for Microtia
Microtia case-management platform - Congenital Microtia
Not applicableRecruitingJing Xu1882026-07-012026-09-29
OSIA System Bilateral Implantation Efficacy Evaluation in Children With Ear Aplasia
Audiological tests, Speech, Spatial and Qualities of Hearing Scale - Deafness Caused by High Grade Microtia or Ear Atresia
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris122026-04-012026-02-13
Social Perception of Microtia
Microtia, Congenital, Auricular Reconstruction
CompletedUniversity Medical Center Groningen12712026-03-042026-07-23
Rib Microtia and the Erector Spinae Plane (ESP) Block
Erector Spinae Plane Block - Microtia, Congenital, Microtia
Not applicableWithdrawnStanford University2025-11-012025-05-04
Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction
Use of AuryzoN™ EAR 2.0 device, Hand carving - Microtia, Congenital, Microtia
Not applicableRecruitingNemours Children's Clinic302025-10-012025-12-29
Safety and Efficacy of Connecting the Residual Ear to the Cartilage Scaffold in First- vs. Second-Stage Surgery
Two-stage connection, One-stage connection - Microtia, Outcome Assessment
Not applicableNot yet recruitingSichuan Provincial People's Hospital782025-06-012025-05-16
The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule
Milk Protein Concentrate, Micellar Casein Isolate - Amino Acid Change, Food Science
Not applicableCompletedNimble Science Ltd.242024-11-102026-10-20
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Vivomixx®, Placebo - Neonatal Jaundice, Microtia
Phase 2UnknownChinese University of Hong Kong942024-03-232024-05-20
Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201
AUR-201 - Microtia
Phase 1 / Phase 2TerminatedAuregen Biotherapeutics, SA12024-01-262025-11-21
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia
AUR-201 - Microtia
Phase 1 / Phase 2TerminatedAuregen Biotherapeutics, SA32024-01-262025-11-21
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder
Urine samples and tissue samples: Samples will be collected in clean leak-proof containers without disinfectant or detergent residue and with tight-fitting leak-proof lids and preserved in a refrigera - Urinary Bladder Neoplasms, Microtia
Active not recruitingTheodor Bilharz Research Institute382023-10-122024-03-01
Effect of Antibiotics on Urinary Microbiome
Bactrim DS 800Mg-160Mg Tablet, Placebo oral tablet - Microtia, UTI
Early Phase 1WithdrawnJohns Hopkins University2023-10-012021-11-03
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Probiotic, Placebo - Microtia, Dysbiosis
Phase 2RecruitingVanderbilt University Medical Center2502023-09-182026-08-27
Nitrate Modulates Cognitive Impairment Via Oral Microbiota.
nitrate-rich beetroot juice, nitrate-depleted beetroot juice - Microtia, Alcohol Dependence
Not applicableCompletedPeking University Sixth Hospital702023-09-102025-06-03
Application and Effectiveness of the Perioperative Position Management Based on the ADDIE Model in Patients With Congenital Microtia
Utilization of a perioperative position management protocol for congenital microtia patients based on the ADDIE model. - Congenital Microtia
Not applicableCompletedEye & ENT Hospital of Fudan University1962023-05-012024-08-26
Clinical Study on the Distribution of Digestive Tract Microbiota Before and After Ileocecal Resection in Crohn's Disease
Crohn Disease, Microtia
UnknownShanghai 10th People's Hospital602022-11-152022-11-14
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
Clostridioides difficile toxin detection - Inflammatory Bowel Diseases, Clostridium Difficile Infections
UnknownRenJi Hospital1002022-11-072023-11-18
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)
AUR-201 - Microtia
Phase 1TerminatedAuregen Biotherapeutics, SA22022-11-042025-11-19
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
No intervention - Acute Lymphoblastic Leukemia, Nutrition Aspect of Cancer
RecruitingColumbia University49002022-10-262025-07-22

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Ear Deformities, Acquired (2)  ·  Goldenhar Syndrome (2)  ·  Insulin Resistance (2)  ·  Metabolic Syndrome (2)  ·  Microtia-Anotia (2)  ·  Agnosia (1)  ·  Airway Obstruction (1)  ·  Alcohol Drinking (1)  ·  Alcoholism (1)  ·  Bacteriuria (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Limb-Threatening Ischemia (1)  ·  Cicatrix (1)  ·  Clostridium Infections (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (33)  ·  Ear Diseases (33)  ·  Otorhinolaryngologic Diseases (33)  ·  Congenital Abnormalities (32)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Pathologic Processes (6)  ·  Infections (4)  ·  Signs and Symptoms (4)  ·  Digestive System Diseases (3)  ·  Hyperinsulinism (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Urogenital Diseases (3)  ·  Body Weight (2)  ·  Bone Diseases (2)

Interventions

Disinfectants (1)  ·  Prebiotics (1)  ·  Preservation, Biological (1)  ·  Probiotics (1)  ·  Silicone Gels (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)  ·  bisphenol A (1)

Sponsors

Auregen Biotherapeutics, SA (3)  ·  Eye & ENT Hospital of Fudan University (2)  ·  Jing Xu (2)  ·  Seattle Children's Hospital (2)  ·  3DBio Therapeutics (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Beijing Tsinghua Chang Gung Hospital (1)  ·  California Polytechnic State University-San Luis Obispo (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chinese University of Hong Kong (1)  ·  Columbia University (1)  ·  Johns Hopkins University (1)  ·  Laval University (1)  ·  Maastricht University (1)

Countries

United States (11)  ·  China (9)  ·  Netherlands (3)  ·  Canada (2)  ·  Egypt (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Brazil (1)  ·  Colombia (1)  ·  France (1)  ·  Guatemala (1)  ·  Honduras (1)  ·  Hong Kong (1)  ·  India (1)  ·  Peru (1)

Top investigators

Thomas Romo, III, MD, FACS (2)  ·  Andrew J Cohen, MD (1)  ·  Angelo A Leto Barone, MD (1)  ·  Angelo Leto Barone (1)  ·  Carrie Heike, MD, MS (1)  ·  Carrie L Heike, MD, MS (1)  ·  Chi C Wang, Professor (1)  ·  Chia-Che Wu, MD (1)  ·  Hannah Brunner-Gaydos (1)  ·  Hongqiang Sun (1)  ·  Joseph Dusseldorp, MD (1)  ·  Liangjun Pang (1)  ·  Matthew L Speltz, PhD (1)  ·  Min Li, professor (1)

Results publications

PMID 21055235, PMID 28886698, PMID 30460424, PMID 21079542, PMID 33185490, PMID 38851232, PMID 39168095, PMID 41638738, PMID 42120725

NIH funding

R01DE022438 (1)